- ICH GCP
- US Clinical Trials Registry
- Forskere
- Sverige
- Trippel negative brystneoplasmer
Medisinske spesialister fra Sverige merket som etterforskere i kliniske studier som studerer Trippel negative brystneoplasmer
Totalt 19 resultater
-
Alaa Haidar, MD, PhDSett i:
- Halmstad, Halmstad Hospital, Department of Surgery
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Anna-Karin Wennstig, MD, PhDSett i:
- Sundsvall, Sundsvall Hospital
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Anne Andersson, MD, PhDSett i:
- Umeå, Norrland University Hospital, Department of Oncology
- Umeå, University Hospital of Umea
Prøver:- NCT04335669 (Hovedetterforsker)
- NCT06223698 (Hovedetterforsker)
Betingelser: -
Antonis Valachis, MD, PhDSett i:
- Örebro, Örebro University Hospital, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Barbro Linderholm, MD, PhDSett i:
- Göteborg, Sahlgrenska University Hospital, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Camilla Wendt, MD, PhDSett i:
- Stockholm, Södersjukhuset, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Cecilia Nilsson, Md, PhDSett i:
- Västerås, Västerås General Hospital
- Västerås, Västmanlands Hopsital Västerås
Prøver:- NCT04335669 (Hovedetterforsker)
- NCT06223698 (Hovedetterforsker)
Betingelser: -
Helena Granstam Björneklett, MD, PhDSett i:
- Västerås, Västmanlands Hopsital Västerås
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Henrik Lindman, MD, PhDSett i:
- Uppsala, Academical Hospital, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Ida Spång Rosén, MDSett i:
- Jönköping, Ryhov Hospital
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Jenny Bergkvist, MD, PhDSett i:
- Stockholm, Capio S:t Göran Hospital, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Kilian Bachmeier, MDSett i:
- Karlstad, Karlstad Hospital
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Lars NorbergSett i:
- Skåne, Kristianstad, Centralsjukhuset i Kristianstad
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Niklas Loman, MD, PhDSett i:
- Lund, Lund University Hospital
- Malmö, Skåne University Hospital, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
- NCT06223698 (Hovedetterforsker)
Betingelser: -
Nina Letter al-Ayoubi, MDSett i:
- Linköping, Linköping University Hospital
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Per Edlund, MD, PhDSett i:
- Gävle, Gävle hospital, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Renske Altena, MD, PhDSett i:
- Stockholm, Karolinska University Hospital
Prøver:- NCT05742269 (Hovedetterforsker)
Betingelser: -
Ulrik Narbe, MD, PhDSett i:
- Växjö, Växjö Hospital, Department of Oncology
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser: -
Zakaria Einbeigi, MD, PhDSett i:
- Borås, Sodra Alvsborgs Hospital
Prøver:- NCT04335669 (Hovedetterforsker)
Betingelser:
Kliniske studier på Trippel negative brystneoplasmer
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UkjentHR-positiv, HER2-negativ og PIK3CA Mutation Advanced Breast CancerKina